IL13 and glioblastoma: W. Debinski et al. found that the receptor for IL-13 is abundantly expressed in human GBM, while there are almost no IL-13 binding sites in the normal human brain, and this selective expression makes it an ideal target for GBM in CAR-T cell therapy [73].